Latest News for: tnf alpha

Edit

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

ACCESSWIRE 07 Apr 2025
BRIDGEWATER, NJ / ACCESS Newswire / April 7, 2025 / Tharimmune, Inc ... Construct. EC50 VEGF. EC50 PD-1. EC50 HER2. EC50 HER3. HS1940 ... - ... The expanded pipeline includes TH023, an oral TNF-alpha inhibitor offering a new approach to treating autoimmune diseases ... .
Edit

Say goodbye to joint pain without surgery: Expert shares 8 tips on diet plan, lifestyle ...

Hindustan Times 04 Apr 2025
Say goodbye to joint pain without surgery ... 1 ... 2 ... 4 ... 5 ... For example, IL-1 and TNF-alpha inhibitors are being used to target inflammatory pathways in osteoarthritis and rheumatoid arthritis, slowing disease progression and improving symptoms. 6 ... 7 ... 8 ... See Less.
Edit

Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or ...

ACCESSWIRE 31 Mar 2025
-Received positive feedback on New Drug Application submission via the 505(b)(2) pathway ... About Tharimmune, Inc ... The expanded pipeline includes TH023, an oral TNF-alpha inhibitor offering a new approach to treating autoimmune diseases ... ... Contacts ... Patel.
Edit

Rheumatoid Arthritis Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight ...

GetNews 31 Mar 2025
... to validate the effectiveness of intravenous (IV) Lymphoseek (Tc 99m tilmanocept) imaging in predicting clinical outcomes in RA patients starting anti-tumor necrosis factor alpha (TNFα) therapy.
Edit

Dr Reddy's inks South East Asia commercialisation, licence pacts with China's Bio-Thera for Stelara, Simponi biosimilars

The Times of India 26 Mar 2025
It prevents shared p40 from binding to the IL-12Rß1 receptor protein expressed on the surface of immune cells.Stelara has been approved for the treatment of moderate to severe plaque psoriasis in ...
Edit

Tharimmune Announces Positive Results for Novel Oral Monoclonal Antibody TH023 Targeting Tumor Necrosis Factor-alpha

ACCESSWIRE 24 Mar 2025
The expanded pipeline includes TH023, an oral TNF-alpha inhibitor offering a new approach to treating autoimmune diseases.
Edit

Do you smoke? Doctor says, cigarettes can affect your mental health in these ways

Hindustan Times 21 Mar 2025
Smoking significantly increases the level of proinflammatory cytokines like IL 6, TNF alpha contributing to chronic inflammation that damages the blood brain barrier and leads to unwanted ...
  • 1
×